propylthiouracil and Glomerulosclerosis--Focal-Segmental

propylthiouracil has been researched along with Glomerulosclerosis--Focal-Segmental* in 1 studies

Other Studies

1 other study(ies) available for propylthiouracil and Glomerulosclerosis--Focal-Segmental

ArticleYear
Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis associated with propylthiouracil therapy.
    Acta paediatrica Japonica : Overseas edition, 1998, Volume: 40, Issue:3

    A teenage girl with crescentic glomerulonephritis had antineutrophil cytoplasmic antibody (ANCA) detected after she had received propylthiouracil (PTU) for hyperthyroidism without cutaneous vasculitis. ANCA was detected on admission; renal biopsy showed crescentic glomerulonephritis with focal necrotizing glomerulonephritis but no immune deposits. Administration of steroid and decreasing the dose of PTU produced a good clinical response and the ANCA disappeared. It was concluded that ANCA is closely related to the pathogenesis of crescentic glomerulonephritis and that treatment with PTU appeared to induce ANCA.

    Topics: Adolescent; Antibodies, Antineutrophil Cytoplasmic; Antithyroid Agents; Female; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Humans; Hyperthyroidism; Necrosis; Propylthiouracil

1998